Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

VEXT Science Inc. (C:VEXT)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for VEXT within the last 6 months
See all filings within the past 6 months

Company News

Nov 27, 2020 06:00 ET
Vext Announces Stock Option Grant
VANCOUVER, BC, Nov. 27, 2020 /CNW/ - Vext Science, Inc. ("VEXT" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it has granted 375,000 stock options to certain employees and consultants of the Company. All of the options are exercisable at a price of CAD$0.75, are fully vested and have a 10-year term.
Read full article
Nov 24, 2020 07:30 ET
VEXT Announces Financial Results for Q3-2020: Arizona Cannabis Operations Drive Adjusted EBITDA of US$2.6 Million, +60% vs. Q2-2020
Revenue of US$8.0 million, + 43% vs. US$5.6 million in Q3-2019; Adjusted EBITDA1 of US$2.6 million, +97% vs. US$1.3 million in the prior year period. With Arizona's transition to adult-use framework in early 2021, VEXT is fully funded for planned expansions and well positioned to continue driving growth and generating value for shareholders. The Company currently operates two dispensaries in the key Phoenix market, a network of cultivation, kitchen and manufacturing facilities; and its Vapen™ brand is currently stocked on the shelves of the vast majority of licensed dispensaries in the State
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 2020127,984-54,407
Oct 31, 2020182,391158,191
Oct 15, 202024,20015,728
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Vext Science, Inc., formerly Vapen MJ Ventures Corporation, is a Canada-based company, which manufactures cannabis tetrahydrocannabinol (THC) and hemp cannabinoid products. The Company manufactures THC cartridges, concentrates, edibles and accessories under the Vapen Brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen cannabidiol (CBD) brand.

See business summary



Search (past week) for $VEXT.CA

  • No tweets found